Your email has been sent.
KEDPLASMA 825 9th St W 16,357 SF Retail Building Bradenton, FL 34205 $4,500,664 ($275.15/SF) 7.25% Cap Rate



INVESTMENT HIGHLIGHTS
- KEDRION S.p.A. guaranty
- 6+ years remain on the primary lease term
- One mile southwest of Manatee Memorial Hospital (300-Bed)
- Florida is an income tax free state
- Proximity to Tamiami Trail (62,500 VPD)
- Over 202,800 people live within a five-mile radius
EXECUTIVE SUMMARY
The 16,357 square-foot building benefits from its strategic location at the intersection of 9th Street and 9th Avenue, which together handle 32,000 vehicles per day. 9th Street connects to US Highway 41, linking Bradenton to Tampa. Additionally, the building is situated near Tamiami Trail, a major thoroughfare in Florida with over 62,500 vehicles passing through daily. KEDPLASMA is found less than one mile southwest of the Manatee Memorial hospital, a 300-bed medical facility. Other key landmarks drawing people to the area include The Bishop Museum of Science and Nature as well as LECOM Park, the spring training home of the Pittsburgh Pirates. There are over 202,800 people living within a five-mile radius that earn an average household income of $80,813.'
KEDPLASMA is a prominent global leader in the collection of high-quality human plasma, operating over 70 plasma donation centers across the United States, and contributing to the collection of approximately 800,000 liters of plasma annually. As a subsidiary of Kedrion Biopharma, an Italian company with over 2,500 employees and a presence in more than 100 countries, KEDPLASMA plays a crucial role in supporting the treatment of rare and serious diseases, such as hemophilia, immune deficiencies, and other blood disorders.
PROPERTY FACTS
AMENITIES
- Bus Line
- Corner Lot
- Pylon Sign
- Signage
- Signalized Intersection
- Monument Signage
MAJOR TENANTS
- TENANT
- INDUSTRY
- SF OCCUPIED
- RENT/SF
- LEASE TYPE
- LEASE END
-
- Health Care and Social Assistance
- -
- -
- Double Net
- May 2032
Kedrion SpA (“Kedrion”) is an international company that collects and fractionates blood plasma to produce and distribute plasma-derived therapeutic products for use in treating and preventing serious diseases, disorders and conditions such as hemophilia, Primary Immune Deficiency and Rh sensitization which can lead to hemolytic disease of the fetus and newborn. Kedrion Biopharma Inc. (“Kedrion Biopharma”), the US subsidiary of Kedrion, is headquartered in Fort Lee, New Jersey. Kedrion Biopharma launched US operations in 2011, but the company’s international roots stretch back several decades in the production of blood and plasma-derived products. It places a high value not only on the welfare of those who benefit from its products but also on the people and communities it serves.
| TENANT | INDUSTRY | SF OCCUPIED | RENT/SF | LEASE TYPE | LEASE END | |
|
Health Care and Social Assistance | - | - | Double Net | May 2032 |
NEARBY MAJOR RETAILERS
PROPERTY TAXES
| Parcel Numbers | Improvements Assessment | $0 | |
| Land Assessment | $0 | Total Assessment | $1,512,299 |
PROPERTY TAXES
Presented by
KEDPLASMA | 825 9th St W
Hmm, there seems to have been an error sending your message. Please try again.
Thanks! Your message was sent.
